Glucotrack Unveils Revolutionary Continuous Blood Glucose Monitor Technology in Upcoming Webinar
TL;DR
Attend the Glucotrack webinar to gain insights on the revolutionary CBGM technology, staying ahead in diabetes management.
Glucotrack's CBGM technology offers continuous blood glucose monitoring with real-time readings, lasting up to three years, without lag time.
Glucotrack's CBGM technology aims to transform diabetes management, providing a less intrusive and more efficient solution for patients.
Join the Glucotrack webinar to discover the future of diabetes management with innovative CBGM technology and real-time continuous glucose monitoring.
Found this article helpful?
Share it with your network and spread the knowledge!
Medical technology company Glucotrack will host a virtual webinar on May 29 to demonstrate its groundbreaking Continuous Blood Glucose Monitor (CBGM) technology, offering potential transformative solutions for diabetes management.
The webinar comes at a critical time as diabetes is projected to impact 643 million people globally by 2030, with numbers expected to rise to 783 million by 2045. Glucotrack's CBGM technology addresses significant limitations in current glucose monitoring methods, which typically require frequent finger pricks and provide limited real-time data.
Unlike traditional continuous glucose monitors, Glucotrack's implantable device offers several key advantages. The technology provides immediate blood glucose readings without the lag time associated with subcutaneous sensors, and its implant can function for two to three years—significantly longer than current market alternatives that require replacement within one year.
A recently completed preclinical study demonstrated the device's potential, showing a Mean Absolute Relative Difference (MARD) of 4.7% at 90 days, which is considered highly accurate in the medical technology field. During the webinar, Glucotrack executives will discuss the device's mechanics, share clinical trial updates, and explore the future of diabetes management.
The event will conclude with a live question-and-answer session, allowing attendees to gain deeper insights into this potentially revolutionary medical technology that could significantly improve patients' quality of life.
Curated from NewMediaWire
